Umeå University's logo

umu.sePublications
Planned maintenance
A system upgrade is planned for 17/11-2026, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Neurosciences. Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.ORCID iD: 0000-0003-0094-5429
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.
Umeå University, Faculty of Medicine, Department of Clinical Sciences, Neurosciences.
Show others and affiliations
1997 (English)In: Brain, ISSN 0006-8950, E-ISSN 1460-2156, Vol. 120, no 10, p. 1723-1737Article in journal (Refereed) Published
Place, publisher, year, edition, pages
Oxford University Press, 1997. Vol. 120, no 10, p. 1723-1737
National Category
Neurology
Identifiers
URN: urn:nbn:se:umu:diva-209900OAI: oai:DiVA.org:umu-209900DiVA, id: diva2:1768263
Available from: 2023-06-15 Created: 2023-06-15 Last updated: 2023-06-15Bibliographically approved
In thesis
1. Amyotrophic lateral sclerosis and CuZn-superoxide dismutase: a clinical, genetic and enzymatic study
Open this publication in new window or tab >>Amyotrophic lateral sclerosis and CuZn-superoxide dismutase: a clinical, genetic and enzymatic study
1997 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative disease characterized by progressive loss of motor neurons in the motor cortex, the brainstem and the ventral horns of the spinal cord. This is clinically manifested as progressive paresis and wasting of the skeletal muscles. Inevitably, the patient expires when the respiratory muscles becomes paralyzed. In Sweden about 180-200 cases of ALS are diagnosed yearly, and the mean survival time from onset is 2.5-3 years. The disease has world-wide distribution but the aetiology is unknown.

In 1993 the finding of missense mutations in the gene enconding the free radical scavenging enzyme CuZn-superoxide dismutase (CuZn-SOD) was reported in a subgroup of North American patients with familial ALS (5- 10% of ALS cases are presumed to be heriditary) suggesting that defective metabolism of superoxide free radicals may be the cause of some cases of ALS.

Objectives of the study:

(I)     To search for mutations in the CuZn-SOD gene in ALS patients in Scandinavia.

(II)     To investigate whether mutations in the CuZn-SOD gene is associated with cases of sporadic ALS.

(III)    To compare the phenotype of ALS patients with different CuZn-SOD mutations.

(IV)     To characterize the metabolism of 027 in ALS patients with different CuZn-SOD mutations.

Methodology: Blood samples were collected from patients with adult-onset motor neuron disease living in Denmark, Finland, Norway and Sweden and screened for CuZn-SOD mutations using PCR-SSCP. In cases with abnormal SSCP- pattern, nucleotide sequencing was performed to identify the mutation. Also, the activity of CuZn-SOD and other free radical scavenging enzymes was measured in the blood. When possible, the patients with a CuZn-SOD mutation were examined and the disease history collected.

Results:

(I)     9.6% of 427 Scandinavian ALS patients were found to have a CuZn-SOD mutation. Five different mutations were found with different genetic and phenotypic characteristics including the first-ever mutation in homozygous form, Asp90Ala. (II) CuZn-SOD mutations were found in 14 patients with apparently sporadic ALS, and in 12 of 51 families with recognized familial ALS.

(III)     The phenotype of patients with the five different CuZn-SOD mutations varied spanning from rapidly progressive disease with only lower motor neuron signs to very slowly evolving disease with affection of both the upper- and lower motor neuron systems. However, the 46 patients homozygous for the D90A CuZn-SOD mutation all showed a remarkable consistent phenotype.

(IV)     The blood activities of CuZn-SOD, EC-SOD and glutathion peroxidase were essentially normal in 44 individuals homozygous for the D90A CuZn-SOD mutation and did not differ from 114 healthy relatives heterozygous for the same mutation. For the other mutations, no association was found between disease phenotype and loss of CuZn-SOD activity as measured in erythrocyte-hemolysate.

Conclusions:

(I)     CuZn-SOD mutations, in particular the D90A CuZn-SOD mutation in homozygous form, are relatively frequent among ALS patients in Scandinavia.

(II)     Apparently sporadic ALS cases may be associated with a CuZn-SOD mutation.

(III)    Patients homozygous for the D90A CuZn-SOD mutation constitutes a well-defined distinct entity of ALS in Scandinavia. (IV) No evidence has been found indicating that the CuZn-SOD mutations confer pathological oxidative stress, rather the mutated CuZn-SOD enzyme causes ALS by a cytotoxic gain-of-function process.

Place, publisher, year, edition, pages
Umeå: Umeå University, 1997. p. 118
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 521
Keywords
CuZn-superoxide dismutase (CuZn-SOD), Amyotrophic lateral sclerosis (ALS), Motor neuron disease (MND), Autosomal recessive adult-onset ALS, Free radicals, Gain-of-function
National Category
Neurosciences Biochemistry Molecular Biology
Identifiers
urn:nbn:se:umu:diva-209916 (URN)91-7191-357-2 (ISBN)
Public defence
1997-11-21, E04, Norrlands universitetssjukhus, Umeå, 13:00 (English)
Projects
digitalisering@umu
Available from: 2023-06-15 Created: 2023-06-15 Last updated: 2025-04-08Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Andersen, Peter M.Forsgren, LarsMarklund, Stefan L.

Search in DiVA

By author/editor
Andersen, Peter M.Forsgren, LarsMarklund, Stefan L.
By organisation
NeurosciencesClinical chemistry
In the same journal
Brain
Neurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 364 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf